Herold Advisors, Inc. Emergent Bio Solutions Inc. Transaction History
Herold Advisors, Inc.
- $455 Million
- Q2 2025
A detailed history of Herold Advisors, Inc. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Herold Advisors, Inc. holds 10,000 shares of EBS stock, worth $100,900. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$100,900
Previous $48,000
31.25%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding EBS
# of Institutions
193Shares Held
39.7MCall Options Held
390KPut Options Held
157K-
Black Rock Inc. New York, NY3.84MShares$38.7 Million0.0% of portfolio
-
Oak Hill Advisors LP New York, NY3.61MShares$36.5 Million2.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.58MShares$36.2 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.29MShares$23.1 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.85MShares$18.7 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $503M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...